164 related articles for article (PubMed ID: 3373265)
1. The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease.
Radford JA; Cowan RA; Flanagan M; Dunn G; Crowther D; Johnson RJ; Eddleston B
J Clin Oncol; 1988 Jun; 6(6):940-6. PubMed ID: 3373265
[TBL] [Abstract][Full Text] [Related]
2. The significance of the residual mediastinal mass in treated Hodgkin's disease.
Jochelson M; Mauch P; Balikian J; Rosenthal D; Canellos G
J Clin Oncol; 1985 May; 3(5):637-40. PubMed ID: 3998780
[TBL] [Abstract][Full Text] [Related]
3. Residual mediastinal widening following therapy in Hodgkin's disease.
Orlandi E; Lazzarino M; Brusamolino E; Caldera D; Morra E; Dore R; Di Giulio G; Bernasconi C
Hematol Oncol; 1990; 8(3):125-31. PubMed ID: 2373490
[TBL] [Abstract][Full Text] [Related]
4. Persistent mediastinal mass is not indicative of recurrence after chemotherapy only in paediatric Hodgkin's disease.
Van Den Berg H; Verhulst L; Behrendt H; Staalman CR
Br J Haematol; 2000 Apr; 109(1):104-8. PubMed ID: 10848788
[TBL] [Abstract][Full Text] [Related]
5. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
[TBL] [Abstract][Full Text] [Related]
6. The value of thoracic computed tomography in the detection of recurrent Hodgkin's disease.
Heron CW; Husband JE; Williams MP; Cherryman GR
Br J Radiol; 1988 Jul; 61(727):567-72. PubMed ID: 3408843
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic significance of mediastinal involvement and post-therapeutic radiographic changes in the intrathoracic area in Hodgkin's disease].
Melínová L; Dienstbier Z; Zámecník J; Hermanská Z; Smakal S; Chytrý P; Maríková E
Cas Lek Cesk; 1990 Oct; 129(42):1332-6. PubMed ID: 2257583
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of Hodgkin's disease with bulky mediastinal involvement. Study of 28 cases].
Acín P; Besses C; Pedro C; Monzó S; Sans-Sabrafén J
Rev Clin Esp; 1997 Nov; 197(11):752-6. PubMed ID: 9547194
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of residual mediastinal-hilar Ga-67 uptake after treatment for Hodgkin's and non-Hodgkin's lymphomas: what degree of Ga-67 uptake is significant?
Nikpoor N; Aliabadi P; Diaz L; Mannting F
Clin Nucl Med; 2000 Dec; 25(12):959-62. PubMed ID: 11129161
[TBL] [Abstract][Full Text] [Related]
10. [Does the residual mediastinal mass have prognostic significance in children with Hodgkin's disease (HD)?].
Klekawka T; Balwierz W; Moryl-Bujakowska A; Stanuch H; Matysiak M; Rokicka-Milewska R; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Chaber R; Sońita-Jakimczyki D; Janik-Moszants A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Adamkiewicz-Drozyińska E; Wysocki M; Koltan A; Krawczuk-Rybako M; Muszyńska-Rosłan K; Stolarska M
Przegl Lek; 2006; 63(1):21-4. PubMed ID: 16892894
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of mediastinal bulk in patients with stage IA-IVB Hodgkin's disease: a report from the Manchester Lymphoma Group.
Anderson H; Jenkins JP; Brigg DJ; Deakin DP; Palmer MK; Todd ID; Crowther D
Clin Radiol; 1985 Sep; 36(5):449-54. PubMed ID: 4075707
[TBL] [Abstract][Full Text] [Related]
12. Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy).
De Lena M; Ditonno P; Lorusso V; Timurian A; Pellecchia A; Brandi M; Berardi F; Marzullo F
Haematologica; 1993; 78(4):230-5. PubMed ID: 7507457
[TBL] [Abstract][Full Text] [Related]
13. Regression of mediastinal Hodgkin disease after therapy: evaluation of time interval.
North LB; Fuller LM; Sullivan-Halley JA; Hagemeister FB
Radiology; 1987 Sep; 164(3):599-602. PubMed ID: 3112862
[TBL] [Abstract][Full Text] [Related]
14. Thoracic CT-scanning follow-up of residual mediastinal masses after treatment of Hodgkin's disease.
Thomas F; Cosset JM; Cherel P; Renaudy N; Carde P; Piekarski JD
Radiother Oncol; 1988 Feb; 11(2):119-22. PubMed ID: 3353516
[TBL] [Abstract][Full Text] [Related]
15. The significance of a residual mediastinal mass following treatment for aggressive non-Hodgkin's lymphomas.
Tredaniel J; Brice P; Lepage E; Bris C; Marolleau JP; Ferme C; Hennequin C; Fermand JP; Frija J; Gisselbrecht C
Eur Respir J; 1992 Feb; 5(2):170-3. PubMed ID: 1559581
[TBL] [Abstract][Full Text] [Related]
16. [Does residual mediastinal mass in children with completed treatment of Hodgkin's disease affect the incidence of relapses?].
Balwierz W; Armata J; Moryl-Bujakowska A; Depowska T; Bogusławska-Jaworska J; Pisarek J; Sońta-Jakimczyk D; Janik-Moszant A; Rokicka-Milewska R; Sopyło B; Kołakowska-Mrozowska B; Radwańska U; Kołecki P; Kaczmarek-Kanold M; Kowalczyk J; Skomra S; Ochocka M; Matysiak M; Newecka-Samól T
Wiad Lek; 1998; 51 Suppl 4():12-7. PubMed ID: 10731938
[TBL] [Abstract][Full Text] [Related]
17. Restaging with gallium scan identifies chemosensitive patients and predicts survival of poor-prognosis mediastinal Hodgkin's disease patients.
Ionescu I; Brice P; Simon D; Guermazi A; Leblanc T; Rousselot P; Gossot D; Meignin V; Gisselbrecht C; Rain JD
Med Oncol; 2000 May; 17(2):127-34. PubMed ID: 10871819
[TBL] [Abstract][Full Text] [Related]
18. Residual masses on follow-up computed tomography in patients with mediastinal non-Hodgkin's lymphoma.
Uematsu M; Kondo M; Tsutsui T; Murase T; Yorozu A; Hiramatsu H; Fujii H; Hashimoto S
Clin Radiol; 1989 May; 40(3):244-7. PubMed ID: 2752680
[TBL] [Abstract][Full Text] [Related]
19. Mediastinal Hodgkin disease in children: response to therapy.
Luker GD; Siegel MJ
Radiology; 1993 Dec; 189(3):737-40. PubMed ID: 8234698
[TBL] [Abstract][Full Text] [Related]
20. Value of sonography in monitoring the therapeutic response of mediastinal lymphoma: comparison with chest radiography and CT.
Wernecke K; Vassallo P; Hoffmann G; Peters PE; Poetter R; Rummeny E; Koch P
AJR Am J Roentgenol; 1991 Feb; 156(2):265-72. PubMed ID: 1898797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
